C-reactive protein and carotid intima-media thickness in atherothrombotic ischemic stroke

被引:3
作者
Arevalo Lorido, Jose Carlos [1 ]
Carretero Gomez, Juana [1 ]
机构
[1] Hosp Zafra, Med Interna Serv, Badajoz, Spain
来源
MEDICINA CLINICA | 2009年 / 133卷 / 13期
关键词
Ischemic stroke; Atherothrombotic infarction; C-reactive protein; CARDIOVASCULAR EVENTS; MARKERS; ATHEROSCLEROSIS; INFLAMMATION; ASSOCIATION; PREDICTION; RISK;
D O I
10.1016/j.medcli.2009.06.051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: We aimed to investigate the relation between values of C-reactive protein (CRP) and carotid artery intima-media thickness (IMT) in patients with atherothrombotic ischemic stroke. Patients and method: One hundred and thirty five patients within 48 h after index ischemic stroke were included. CRP levels were obtained at this time and a carotid ultrasonography was performed. Neurological and functional disability were evaluated, and all patients under-went a cardiovascular risk stratification. Patients were divided in three groups according to the tertiles of they IMT distribution. We adjusted for the possible confounding effect using a multivariate logistic model. Results: Forty three in-patients were classified into group 1 (IMT between 0.7 and 1.1 millimetres), 43 into group 2 (IMT between 1.2 and 1.5 millimetres) and 49 into group 3 (IMT higher of 1.6 millimetres). We found a significant elevation of CRP levels at different groups (p<0.0008), with medians by group of 0.3, 0.4 and 1.5 mg/dl respectively. Likewise, we found significant differences by group in functional disability (p<0.03) and in vascular risk stratification (p<0.02). Conclusions: CRP is a marker of increased IMT in patients with atherothrombotic ischemic stroke. A cutoff point of 1.5 mg/dl for CRP provided a greater IMT and a worse outcome in functional disability as cardiovascular risk. Therefore, this group requires a more intensive treatment in secondary prevention. (C) 2009 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:496 / 500
页数:5
相关论文
共 17 条
[1]  
Arboix A., 1998, NEUROLOGIA S1, V13, P1
[2]  
Baena-Díez JM, 2009, NEUROLOGIA, V24, P24
[3]   C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J].
Danesh, J ;
Wheeler, JG ;
Hirschfield, GM ;
Eda, S ;
Eiriksdottir, G ;
Rumley, A ;
Lowe, GDO ;
Pepys, MB ;
Gudnason, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1387-1397
[4]   Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients [J].
Di Napoli, M ;
Papa, F .
STROKE, 2002, 33 (07) :1763-1771
[5]   C-reactive protein and outcome after first-ever ischemic stroke [J].
Di Napoli, M ;
Di Gianfilippo, G ;
Sollecito, A ;
Bocola, V .
STROKE, 2000, 31 (01) :238-239
[6]   C-reactive protein in ischemic stroke - An independent prognostic factor [J].
Di Napoli, M ;
Papa, F ;
Bocola, V .
STROKE, 2001, 32 (04) :917-924
[7]   Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats [J].
Gill, R ;
Kemp, JA ;
Sabin, C ;
Pepys, MB .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2004, 24 (11) :1214-1218
[8]   Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].
Hacke, W ;
Kaste, M ;
Fieschi, C ;
von Kummer, R ;
Davalos, A ;
Meier, D ;
Larrue, V ;
Bluhmki, E ;
Davis, S ;
Donnan, G ;
Schneider, D ;
Diez-Tejedor, E ;
Trouillas, P .
LANCET, 1998, 352 (9136) :1245-1251
[9]   Biomarkers of atherosclerotic plaque instability and rupture [J].
Koenig, Wolfgang ;
Khuseyinova, Natalie .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (01) :15-26
[10]   High-sensitivity C-reactive protein is not associated with carotid intima-media progression - The carotid atherosclerosis progression study [J].
Lorenz, Matthias W. ;
Karbstein, Peter ;
Markus, Hugh S. ;
Sitzer, Matthias .
STROKE, 2007, 38 (06) :1774-1779